Obinutuzumab shows preliminary efficacy and safety in adolescents with active lupus nephritis. Investigators presented primary findings from the POSTERITY phase 2 trial at the American Society of ...

Daratumumab was associated with rapid improvement in serology in the 9 patients with active lupus nephritis, but some relapses occurred.

Crude odds ratios suggest increased risk for AMD, which was reversed after accounting for cardiometabolic confounders.

In a survey study, surrogates were less likely to recommend LST for patients with versus without dementia, even when advance directives request all care possible.